Renbok Phenomenon and Contact Sensitization in a Patient With Alopecia Universalis

被引:0
作者
Harris, John E. [1 ]
Seykora, John T. [1 ]
Lee, Robert A. [1 ]
机构
[1] Hosp Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
关键词
T-HELPER-CELL; AREATA; PSORIASIS; DIPHENYLCYCLOPROPENONE; LYMPHOCYTES; DISTINCT; LINEAGE;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Immune responses are largely regulated by cytokines that are secreted by activated T cells. Interactions among these cells are complex, and the interaction between 2 responses may alter the effect of either response alone. It has been established that contact sensitization-induced inflammation can reverse hair loss due to alopecia areata. In parallel, the Renbok phenomenon demonstrates how 2 distinct autoimmune diseases-psoriasis and alopecia areata-interact to result in clinically active psoriasis suppressing alopecia areata. Observations: We describe a patient with concurrent psoriasis and alopecia universalis with terminal hairs within plaques on his extremities, representing the only normal hair growth on his body. Adjacent biopsy specimens confirmed our clinical suspicion of plaque psoriasis with normal hair follicles and alopecia universalis with a peribulbar lymphocytic infiltrate. Our patient's psoriatic plaques cleared rapidly with narrow-band UV-B phototherapy, but hair growth at the site was maintained. His scalp alopecia responded to squaric acid dibutyl-ester contact sensitization therapy. Conclusions: This case represents a natural experiment in which 3 distinct but overlapping immune responses favored psoriasis or contact dermatitis over alopecia areata. The precise mechanism responsible for these effects remains unclear; however, based on recent reports, we speculate that cytokine cross-regulation plays a role in competition among these distinct immune responses. Arch Dermatol. 2010; 146(4): 422-425
引用
收藏
页码:422 / 425
页数:4
相关论文
共 50 条
  • [11] Successful treatment of refractory alopecia universalis by persuading a patient not to sleep with her dog
    Arita, Takahiro
    Nomiyama, Tomoko
    Asai, Jun
    Katoh, Norito
    ALLERGOLOGY INTERNATIONAL, 2018, 67 (01) : 156 - 157
  • [12] SUCCESSFUL HAIR REGROWTH IN A KOREAN PATIENT WITH ALOPECIA UNIVERSALIS FOLLOWING TOFACITINIB TREATMENT
    Young, Bo
    Kim, Hyun-Sook
    SINGAPORE MEDICAL JOURNAL, 2017, 58 (05) : 279 - 280
  • [13] Diphenylcyclopropenone alleviates trachyonychia in alopecia universalis
    Yorulmaz, Ahu
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (11) : 1615 - 1617
  • [14] Alopecia universalis in a dog with testicular neoplasia
    Outerbridge, Catherine A.
    White, Stephen D.
    Affolter, Verena K.
    VETERINARY DERMATOLOGY, 2016, 27 (06) : 513 - +
  • [15] Ocular Myasthenia Gravis and Alopecia Universalis
    Kiylioglu, Nefati
    JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, 2017, 34 (01): : 114 - 117
  • [16] A Case Report Highlighting the Effective Treatment of Alopecia Universalis With Tofacitinib in an Adolescent and Adult Patient
    Patel, Nupur U.
    Oussedik, Elias
    Grammenos, Alexandra
    Pichardo-Geisinger, Rita
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2018, 22 (04) : 439 - 442
  • [17] Remission of Alopecia Universalis after 1 Year of Treatment with Dupilumab in a Patient with Severe Atopic Dermatitis
    Romagnuolo, Maurizio
    Barbareschi, Mauro
    Tavecchio, Simona
    Angileri, Luisa
    Ferrucci, Silvia Mariel
    SKIN APPENDAGE DISORDERS, 2022, 8 (01) : 38 - 41
  • [18] Overall and demographic subgroup incidences of alopecia areata, alopecia totalis, and alopecia universalis in the United States
    Kang, Inkyu E.
    Strunk, Andrew
    Garg, Amit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (01) : 162 - 165
  • [19] Efficacy of tofacitinib in treatment of alopecia universalis in two patients
    Gupta, A. K.
    Carviel, J. L.
    Abramovits, W.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (08) : 1373 - 1378
  • [20] Case of alopecia universalis associated with alemtuzumab treatment in MS
    Leussink, Verena Isabell
    Reifenberger, Julia
    Hartung, Hans-Peter
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2018, 5 (03):